Global Prenatal and New-born Genetic Testing Market Report 2022 to 2027: Players Include Agilent Technologies, AutoGenomics, Baebies and Berry Genomics –

Global Prenatal and New-born Genetic Testing Market Report 2022 to 2027: Players Include Agilent Technologies, AutoGenomics, Baebies and Berry Genomics –

Global Prenatal and New-born Genetic Testing Market Report 2022 to 2027: Players Include Agilent Technologies, AutoGenomics, Baebies and Berry Genomics –

DUBLIN–(BUSINESS WIRE)–The “Global Prenatal and New-born Genetic Testing Market (2022-2027) by Type, Technology, Application, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to’s offering.

The Global Prenatal and New-born Genetic Testing Market is estimated to be USD 8.03 Bn in 2022 and is expected to reach USD 14.34 Bn by 2027, growing at a CAGR of 12.3%

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.

There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Prenatal and New-born Genetic Testing Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Prenatal and New-born Genetic Testing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Prenatal and New-born Genetic Testing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.

Market Dynamics


  • Growing Application of Genetic Testing in Oncology and Genetic Diseases
  • Growing Adoption of Precision Medicine Diagnostic Techniques
  • Rising Implementation of Personalized Medicine Applications to Treat Chronic Disorders
  • Growing Demand for Direct-To-Consume


  • Lack of Experienced Professionals
  • Social and Ethical Implications of Genetic Testing


  • Stringent Regulatory for Product Approvals
  • Technological Advances in the Field of Genetic Testing and Panels for ECS


  • High Cost of Next Generation Sequencing

Market Segmentation

The Global Prenatal and New-born Genetic Testing Market is segmented based on Type, Technology, Application, and Geography.

  • By Type, the market is classified into Carrier Testing, Diagnostic Testing, Newborn Screening, Pharmacogenomics, Preimplantation Testing, Prenatal Testing, and Presymptomatic and Predictive Testing.
  • By Technology, the market is classified into Cytogenetics, DNA Sequencing, Gene Expression Profiling, Microarrays PCR.
  • By Application, the market is classified into Autoimmune Disorders, Cancer, Chronic Diseases, Genetic Disorders, Neurodegenerative Diseases.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • AutoGenomics
  • Baebies
  • Berry Genomics Co., Ltd.
  • BGI
  • Biocartis Group NV
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc
  • Laboratory Corporation of America
  • Masimo Corp.
  • Natera, Inc.
  • PerkinElmer, Inc.
  • Progenity, Inc.
  • Qiagen
  • Sequenom, Inc.
  • Trivitron Healthcare Pvt. Ltd.

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900